| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors |
| 05/12/2005 | US20050100617 Method for improving age-related physiological deficits and increasing longevity |
| 05/12/2005 | US20050100616 Administering plant extracts; health food; allergies |
| 05/12/2005 | US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response |
| 05/12/2005 | US20050100540 Platelet-activating factor acetylhydrolase |
| 05/12/2005 | US20050100534 firoin and firoin-A from extremophilic microorganisms ; active protection and stabilization of skin cells and their organic constituents (proteins, enzymes, membranes, nucleic acids or antioxidants); against damaging environmental influences, UV radiation. |
| 05/12/2005 | US20050098502 filtration of coal tar to remove impurities, then adding zinc pyrithione, surfactants and carriers to form mixtures used for the treatment of skin disorders |
| 05/12/2005 | CA2544377A1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 05/12/2005 | CA2544125A1 Use of ephrins and related molecules to regulate cellular proliferation |
| 05/12/2005 | CA2544107A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2543530A1 Use of biocompatible polymers for the preparation of a composition or a medical device |
| 05/12/2005 | CA2543198A1 Personal care composition containing a detersive surfactant, an antidandruff component, and ketoamide surfactants |
| 05/12/2005 | CA2543135A1 Methods and compositions for treating 5alpha-reductase type 1 and type 2 dependent conditions |
| 05/11/2005 | EP1529522A1 Peeling composition comprising vitamin B3 and vitamin C |
| 05/11/2005 | EP1529520A1 Use of licochalcone A or a licochalcone A containing extract from Radix Glycyrrhizae inflatae against postinflammatory hyperpigmentation |
| 05/11/2005 | EP1529047A2 New purine derivatives |
| 05/11/2005 | EP1529046A1 Substituted benzimidazole compounds |
| 05/11/2005 | EP1529038A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/11/2005 | EP1257526B1 Aniline-derived ligands for the thyroid receptor |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1165017B1 Liquid dispersion polymer compositions, their preparation and their use |
| 05/11/2005 | EP1140124B1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
| 05/11/2005 | EP1105738B1 Assays for modulating nuclear localisation |
| 05/11/2005 | EP1084711B1 Remedies for the treatment of itching containing pgd2 antagonists |
| 05/11/2005 | EP1076563B1 Dipeptide caspase inhibitors and the use thereof |
| 05/11/2005 | EP0986408B1 New medicaments based on polymers composed of methacrylamide-modified gelatin |
| 05/11/2005 | CN1615357A Process for the manufacture of human mononuclear phagocytic leukocytes |
| 05/11/2005 | CN1615159A Preparation for wound healing and prevention of bandage adhesion to the wound |
| 05/11/2005 | CN1615155A Anti-proliferative composition |
| 05/11/2005 | CN1615152A Method for reducing acne or improving skin tone |
| 05/11/2005 | CN1615149A Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/11/2005 | CN1615148A Methods and compositions for derepression of IAP-inhibited caspase |
| 05/11/2005 | CN1615138A Melanogenesis inhibitors and whitening agents comprising ergosterol derivatives and compositions containing ergosterol derivatives |
| 05/11/2005 | CN1615132A Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| 05/11/2005 | CN1613502A Bactoria oral liquid for nourishing face and removing freckles |
| 05/11/2005 | CN1613501A Multifunctional psora sterilizing liquid |
| 05/11/2005 | CN1613499A Composite Chinese medicinal prescription for dispelling spot |
| 05/11/2005 | CN1613497A Composite Chinese medicinal prescription for breeding and blackening hair |
| 05/11/2005 | CN1613496A Chinese medicine for treating scar |
| 05/11/2005 | CN1613495A Chinese medicine preparation for treating bromhidrosis |
| 05/11/2005 | CN1613494A External used medicine for inhibiting fungus |
| 05/11/2005 | CN1613489A Compound preparation its preparing method and use |
| 05/11/2005 | CN1613477A Medicine composition with spot dispelling function and preparation thereof |
| 05/11/2005 | CN1613464A Liquid medicine composition for external-applied anti-inflammation and antipruritic |
| 05/11/2005 | CN1613456A Freezing dried mycobatctericsis preparation and its preparing method and use |
| 05/11/2005 | CN1200951C Process for productio nof multiple cross-linked hyaluronic acid derivatives |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200721C Chinese medicineal powder for treating alopecia areata, male pattern alopecia and juvenile hoany hair |
| 05/11/2005 | CN1200720C Ointment for treating burn and its preparing process |
| 05/11/2005 | CN1200717C External use burn treating medicine and its preparation |
| 05/11/2005 | CN1200714C Use of diterpenoid triepoxides as anti-proliferative agent |
| 05/11/2005 | CN1200706C Compositions and methods for treating or preventing inflammatory diseases |
| 05/11/2005 | CN1200704C Appliance of probucol monoesters for treatment of cardiovascular and inflammatory disease |
| 05/11/2005 | CN1200692C Nanoemulsion based on nonionic amphiphilic lipids and aminated silicones and uses |
| 05/11/2005 | CN1200687C Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology |
| 05/11/2005 | CN1200679C Weak ethoxylation dehydrated sorbitol ester composition of washing keratin material |
| 05/11/2005 | CN1200673C Antimicotic nail varnish composition |
| 05/10/2005 | US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 05/10/2005 | US6891063 Salts with pharmaceutically acceptable organic bases, selected from ethylenediamine, ethanolamine, diethanolamine, lysine, benzyltrimethylammonium hydroxide and tetramethylammonium hydroxide; antiinflammatory agents, wound healing agents |
| 05/10/2005 | US6890959 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea |
| 05/10/2005 | US6890952 Administering cyclic substituted aminomethyl compounds for the preparation of a drug for the treatment of pain, urinary incotinence, itching, tinnitus aurium or diarrhea in a mammal |
| 05/10/2005 | US6890938 Antiinflammatory agents |
| 05/10/2005 | US6890929 Immunosuppressants; lupus, multiple sclerosis, skin disorders, antiarthritic agents, antihistamines, antiulcer agents, Crohn's disease |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | US6890914 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 05/10/2005 | US6890903 Prevention accumulation of fluid at site of injury, surgery |
| 05/10/2005 | US6890547 Glycyrrhizin preparations for transmucosal absorption |
| 05/10/2005 | US6890545 Fungicide and method for producing the same |
| 05/10/2005 | US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas |
| 05/10/2005 | CA2250569C Novel phenanthridines substituted in the 6 position |
| 05/10/2005 | CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use |
| 05/10/2005 | CA2116192C Highly concentrated tcf pharmaceutical preparations |
| 05/10/2005 | CA2111193C Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer |
| 05/06/2005 | WO2005040172A1 Tricyclic proline derivative |
| 05/06/2005 | WO2005040148A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 05/06/2005 | WO2005039621A1 Fibroblast-mobilizing agent containing g-csf and wound remedy |
| 05/06/2005 | WO2005039607A1 The use of balloonfish collagen i extractive in medical care and the preparative method of it |
| 05/06/2005 | WO2005039602A1 Pharmacologically functional water and use thereof |
| 05/06/2005 | WO2005039599A1 Matrix metalloprotease inhibitor containing polylactic acid mixture |
| 05/06/2005 | WO2005039523A1 Composition comprising a sesquiterpene lactone |
| 05/06/2005 | WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/06/2005 | WO2002095007A3 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 05/06/2005 | CA2543870A1 Therapeutic use of methionine for the treatment or prevention of mucositis |
| 05/06/2005 | CA2543817A1 Fibroblast-mobilization agent containing a g-csf for repair of myocardial infarct lesion |
| 05/06/2005 | CA2542708A1 Dna delivery with gemini cationic surfactants |
| 05/06/2005 | CA2539193A1 New rarbeta receptor-activating ligand, method for the preparation ther eof and use thereof in human medicine and in cosmetics |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096356 2-[[6-Methoxy-3-pyridinyl]methyl]amino-N-[3-(trifluoromethyl)phenyl]benzamide hydrochloride salt or its tautomer; treating retinopathy or age-related macula degeneration |
| 05/05/2005 | US20050096335 Heteroaryl - fused nitrogen heterocycles as therapeutic agents |
| 05/05/2005 | US20050096321 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 05/05/2005 | US20050096316 Quinoline derivatives(2) |
| 05/05/2005 | US20050096313 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic |